Qurient Co Ltd

XKRX:115180 (Korea (the Republic of))  
â‚© 3780.00 (-5.97%) Jul 16
At Loss
P/B:
2.50
Market Cap:
â‚© 119.85B ($ 86.67M)
Enterprise V:
â‚© 82.65B ($ 59.77M)
Volume:
188.18K
Avg Vol (2M):
137.36K
Trade In:
Volume:
188.18K
At Loss

Business Description

Description
Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.
Name Current Vs Industry Vs History
Cash-To-Debt 164.12
Equity-to-Asset 0.88
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 24.57
Distress
Grey
Safe
Beneish M-Score -1.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.98
9-Day RSI 62.95
14-Day RSI 58.59
6-1 Month Momentum % -18.67
12-1 Month Momentum % -36.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.42
Quick Ratio 18.34
Cash Ratio 17.78
Days Inventory 8.84
Days Sales Outstanding 36.71
Days Payable 11.37

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.9
Shareholder Yield % 0.39